Darling Ingredients’ health and nutrition brand Rousselot has been granted a patent by the United States Patent and Trademark Office for its blood glucose-regulating collagen peptide, Nextida GC.
The patent, designated as Patent No. US12636339, protects both the specific manufacturing process and the formulation of Nextida GC for use in dietary supplements. The regulatory approval provides nutritional brand owners with a scientifically validated, non-pharmaceutical ingredient option designed to manage post-meal blood glucose levels naturally.
The development of Nextida GC aligns with a growing consumer and commercial shift towards preventative metabolic health solutions. By targeting post-meal glucose spikes, the ingredient addresses a key area of focus within the active nutrition and wellness supplement sectors.
Scientific Validation
Nextida GC is a specialised collagen peptide composition formulated specifically for dietary supplements, functional foods, and metabolic health applications. The product is the first entry in an expanding portfolio of targeted collagen solutions developed by Rousselot to address distinct functional health needs.
According to Randall C. Stuewe, Chairman and Chief Executive Officer of Darling Ingredients, the patent strengthens the scientific foundation of the Nextida brand. He noted that the approval demonstrates the company's ability to translate its collagen processing expertise into high-value, targeted wellness ingredients as international demand for functional metabolic support continues to rise.
International Patent Network
In addition to securing intellectual property protection in the United States, Rousselot has established a broad global patent network for Nextida GC to support international commercialisation.
To date, patents for the ingredient have been officially awarded in several major global markets:
North America – United States
Europe – European Patent Office
Asia-Pacific – Japan and China
Oceania – Australia
The company is currently pursuing additional patent applications for Nextida GC in other key agricultural and consumer regions, including Brazil, Canada, Colombia, South Korea, Mexico, India, and Peru.
Corporate Profiles
Rousselot operates as the health and nutrition brand of Darling Ingredients, specialising in gelatin- and collagen-based solutions for the food, pharmaceutical, and biomedical sectors.
Darling Ingredients is a major global processor of organic materials, converting agricultural by-products into functional ingredients, feeds, and renewable energy. The multinational operates more than 260 facilities across 15 countries, producing approximately 30% of the world's collagen and gelatin supply.
